Provided by Tiger Fintech (Singapore) Pte. Ltd.

AxoGen

13.72
+1.179.32%
Post-market: 13.70-0.0200-0.15%19:46 EDT
Volume:4.95M
Turnover:68.20M
Market Cap:624.86M
PE:-85.72
High:14.92
Open:14.90
Low:12.75
Close:12.55
Loading ...

AxoGen Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Yesterday

Axogen Inc. Releases Presentation on Advancements in Peripheral Nerve Care and Repair

Reuters
·
Yesterday

AxoGen Shares Surge 16.3% Premarket After Raising FY Revenue Guidance

THOMSON REUTERS
·
Yesterday

Stock Track | AxoGen Soars 8.61% Pre-market on Strong Q2 Results and Raised Guidance

Stock Track
·
Yesterday

Axogen Inc. Reports Q2 2025 Results: Revenue Up 18.3%, Net Income at $0.6M, EPS at $0.01

Reuters
·
Yesterday

BRIEF-AxoGen Q2 Revenue USD 56.7 Million Vs. IBES Estimate USD 52.7 Million

Reuters
·
Yesterday

AxoGen Q2 Net Income USD 600 Thousand

THOMSON REUTERS
·
Yesterday

AxoGen Outlook FY Revenue USD 219 Million

THOMSON REUTERS
·
Yesterday

AxoGen, Inc. Reports Second Quarter 2025 Financial Results

THOMSON REUTERS
·
Yesterday

Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference

GlobeNewswire
·
30 Jul

AxoGen exploring possible sale after approach, Street Insider says

TIPRANKS
·
30 Jul

Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025

GlobeNewswire
·
23 Jul

Axogen Inc. Conducted Annual Shareholder Meeting, Voting on Key Proposals Completed

Reuters
·
21 Jun

Director William P. Burke Reports Disposal of Common Shares of Axogen Inc

Reuters
·
12 Jun

Cantor Fitzgerald Reaffirms Their Buy Rating on AxoGen (AXGN)

TIPRANKS
·
02 Jun

Axogen Inc. to Participate in Goldman Sachs Global Healthcare Conference

Reuters
·
28 May

Director Joseph A. Tyndall Reports Disposal of Common Shares of Axogen Inc

Reuters
·
24 May

Axogen Inc. Files Initial Statement of Beneficial Ownership for Lindsey Marie Hartley

Reuters
·
17 May

Axogen Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
13 May

Stock Track | AxoGen Plummets 5.16% as Leerink Partners Slashes Target Price

Stock Track
·
09 May